Multimodality functional imaging in cancer treated with radiotherapy


Dr Tessa Greenhalgh, University of Oxford

Date & Time:

Tuesday, 31 October 2017, 13:00

Old Road Campus Research Building, Room 71a, b & c, Headington OX3 7DQ
CRUK & EPSRC Cancer Imaging Centre in Oxford

Functional imaging has many potential uses in cancer: as a predictive biomarker, for directing radiotherapy or targeted systemic therapy and in assessment of response. However, these have to date found limited use clinically. The investigation of both established imaging methods (perfusion CT and MRI, FMISO- and FDG-PET) and novel functional imaging techniques (CEST and oxygen-enhanced MRI) through longitudinal imaging studies of patients undergoing radiotherapy will be presented. Comparison with histopathological assessment and the potential to combine imaging with genetic data to provide a tailored management plan for patients with cancer will be discussed

About Us
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.